News - Respiratory and Pulmonary, Anti-virals


Popular Filters

Forest Laboratories announces new appointments to its executive team


New York-based pharmaceutical company Forest Laboratories (NYSE: FRX) has announced new appointments…

Anti-viralsBoardroomCardio-vascularCNS DiseasesForest LaboratoriesGastro-intestinalsPharmaceuticalRespiratory and PulmonaryUSA

New agreement with GSK provides new medicines, saves millions for New Zealand

New agreement with GSK provides new medicines, saves millions for New Zealand


A new agreement with the local subsidiary of UK pharma giant GlaxoSmithKline by New Zealand’s Pharmaceutical…

Anti-viralsAsia-PacificGlaxoSmithKlineHealthcareHematologyNew ZealandPharmaceuticalPricingRespiratory and PulmonarySeretideSerevent Diskus

Regulatory updates for Tris Pharma's Karbinal; GSK's four-strain seasonal flu vaccine


US drug delivery specialist Tris Pharma says that the US Food and Drug Administration has approved its…

Anti-viralsEuropeFluarixGlaxoSmithKlineInflusplit TetraKarbinalNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTris Pharma

Mylan debuts generic Epivir in Europe; gets Canadian OK for Tracleer copy


US generic drugs major Mylan (Nasdaq: MYL) says that its UK and Italy-based subsidiaries have launched…

ActelionAnti-viralsEpivirEuropeGenericsGlaxoSmithKlineMarkets & MarketingMylan LaboratoriesNorth AmericaRegulationRespiratory and PulmonaryTracleer

South Africa debuts new five-year HIV and tuberculosis plan


Coinciding with Worlds AIDS day last week, the South African government launched its new national strategic…

Anti-viralsHealthcarePharmaceuticalRespiratory and PulmonaryRest of the World

Teva gets BDP allergy drug NDA accepted by FDA; sued by ViiV over Epzicom


The US Food and Drug Administration has accepted for filing Israeli generics giant Teva Pharmaceutical…

Anti-viralsEpzicomGenericsGlaxoSmithKlineLegalNorth AmericaPatentsPfizerPharmaceuticalRegulationRespiratory and PulmonaryTeva Pharmaceutical IndustriesViiV Healthcare

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top